Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion.

MLA

Zhang, Xiaojun, et al. “Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion.” Journal of Medicinal Chemistry, vol. 64, no. 7, Apr. 2021, pp. 4179–95. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c00117.

APA

Zhang, X., Wu, Y., Zeng, Q., Xie, T., Yao, S., Zhang, J., & Cui, M. (2021). Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion. Journal of Medicinal Chemistry, 64(7), 4179–4195. https://doi.org/10.1021/acs.jmedchem.1c00117

Chicago

Zhang, Xiaojun, Yitian Wu, Qi Zeng, Tianxin Xie, Shulin Yao, Jinming Zhang, and Mengchao Cui. 2021. “Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion.” Journal of Medicinal Chemistry 64 (7): 4179–95. doi:10.1021/acs.jmedchem.1c00117.